Loading...
Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects
Recent studies have highlighted the successes of chimeric antigen receptor-modified T- (CART-) cell-based therapy for B-cell malignancies, and early phase clinical trials have been launched in recent years. The few published clinical studies of CART cells in solid tumors have addressed safety and fe...
Na minha lista:
| Udgivet i: | J Immunol Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Hindawi Publishing Corporation
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4779545/ https://ncbi.nlm.nih.gov/pubmed/26998495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/3850839 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|